1. The price of innovation: new estimates of drug development costs (see comment);DiMasi;J. Health Econ.,2003
2. Timing of new black box warnings and withdrawals for prescription medications [see comment];Lasser;JAMA,2002
3. Concordance of the toxicity of pharmaceuticals in humans and in animals;Olson;Regul. Toxicol. Pharmacol.,2000
4. Drug-induced hepatotoxicity;Lee;N. Engl. J. Med.,2003
5. F. Borde, F. Lagelle, V.E. Bender, M. Bouskila, M.-C. Bonnet, P. Brizard, M.-T. Masson, S. Chevalier, C. Charuel, D. Cassio, C.P. Biagini, Characterisation of hepatotoxicity profiles and metabolism-related toxicity in rat liverbeads and WIF-B9 cell line, in: Proceedings of the 11th North American ISSX Meeting, Orlando, FL, 2002.